H-103

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH-103
Drug Alias NameH-103
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionHeat shock 70 kDa protein 1 stimulantsTumor protein p53 stimulants
TargetsHeat shock 70 kDa protein 1Tumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Sunway Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Sunway Bio Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A